| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| DVA - DaVita HealthCare Partners Inc | SELL | -20 @ USD 121.16 | USD -2,423 | The ETF sold 20 shares of DVA on 2025-11-05. The shares were previously bought for an average price of USD 146.906. The DaVita HealthCare Partners Inc shares were sold for -17.5% lower than average price of previous purchases. This resulted in an overall loss of USD 515 The average price that the ETF previously sold DVA share for is USD 142.753 which is higher than the selling price of USD 121.16 on 2025-11-05. |
| HSIC - Henry Schein Inc | SELL | -57 @ USD 72.01 | USD -4,105 | The ETF sold 57 shares of HSIC on 2025-11-05. The shares were previously bought for an average price of USD 70.8086. The Henry Schein Inc shares were sold for 1.7% higher than average price of previous purchases. This sale made a profit of USD 68 The average price that the ETF previously sold HSIC share for is USD 69.7724 so the ETF has sold 57 shares on 2025-11-05 at a higher price than the previous selling average. |
| MRNA - Moderna Inc | SELL | -186 @ USD 23.56 | USD -4,382 | The ETF sold 186 shares of MRNA on 2025-11-05. The shares were previously bought for an average price of USD 32.2658. The Moderna Inc shares were sold for -27.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,619 The average price that the ETF previously sold MRNA share for is USD 37.3677 which is higher than the selling price of USD 23.56 on 2025-11-05. |
| MOH - MOH | SELL | -30 @ USD 149.75 | USD -4,493 | The ETF sold 30 shares of MOH on 2025-11-05. The shares were previously bought for an average price of USD 272.103. The MOH shares were sold for -45.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,671 The average price that the ETF previously sold MOH share for is USD 294.439 which is higher than the selling price of USD 149.75 on 2025-11-05. |
| MOH - LVMH Moët Hennessy - Louis Vuitton Société Européenne | SELL | -30 @ USD 149.75 | USD -4,493 | The ETF sold 30 shares of MOH on 2025-11-05. The shares were previously bought for an average price of USD 272.103. The LVMH Moët Hennessy - Louis Vuitton Société Européenne shares were sold for -45.0% lower than average price of previous purchases. This resulted in an overall loss of USD 3,671 The average price that the ETF previously sold MOH share for is USD 294.439 which is higher than the selling price of USD 149.75 on 2025-11-05. |
| CRL - Creightons Plc | SELL | -27 @ USD 167.7 | USD -4,528 | The ETF sold 27 shares of CRL on 2025-11-05. The shares were previously bought for an average price of USD 167.44. The Creightons Plc shares were sold for 0.2% higher than average price of previous purchases. This sale made a profit of USD 7 The average price that the ETF previously sold CRL share for is USD 173.677 which is higher than the selling price of USD 167.7 on 2025-11-05. |
| BAX - Baxter International Inc | SELL | -278 @ USD 17.95 | USD -4,990 | The ETF sold 278 shares of BAX on 2025-11-05. The shares were previously bought for an average price of USD 29.9863. The Baxter International Inc shares were sold for -40.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,346 The average price that the ETF previously sold BAX share for is USD 31.5795 which is higher than the selling price of USD 17.95 on 2025-11-05. |
| ALGN - Align Technology Inc | SELL | -37 @ USD 137.21 | USD -5,077 | The ETF sold 37 shares of ALGN on 2025-11-05. The shares were previously bought for an average price of USD 175.554. The Align Technology Inc shares were sold for -21.8% lower than average price of previous purchases. This resulted in an overall loss of USD 1,419 The average price that the ETF previously sold ALGN share for is USD 201.089 which is higher than the selling price of USD 137.21 on 2025-11-05. |
| TECH - Bio-Techne Corp | SELL | -86 @ USD 59.94 | USD -5,155 | The ETF sold 86 shares of TECH on 2025-11-05. The shares were previously bought for an average price of USD 62.5999. The Bio-Techne Corp shares were sold for -4.2% lower than average price of previous purchases. This resulted in an overall loss of USD 229 The average price that the ETF previously sold TECH share for is USD 65.1077 which is higher than the selling price of USD 59.94 on 2025-11-05. |
| SOLV - Solventum Corp. | SELL | -81 @ USD 67.69 | USD -5,483 | The ETF sold 81 shares of SOLV on 2025-11-05. The shares were previously bought for an average price of USD 73.4502. The Solventum Corp. shares were sold for -7.8% lower than average price of previous purchases. This resulted in an overall loss of USD 467 The average price that the ETF previously sold SOLV share for is USD 72.0251 which is higher than the selling price of USD 67.69 on 2025-11-05. |
| RVTY - Revvity Inc. | SELL | -65 @ USD 92.57 | USD -6,017 | The ETF sold 65 shares of RVTY on 2025-11-05. The shares were previously bought for an average price of USD 106.198. The Revvity Inc. shares were sold for -12.8% lower than average price of previous purchases. This resulted in an overall loss of USD 886 The average price that the ETF previously sold RVTY share for is USD 106.911 which is higher than the selling price of USD 92.57 on 2025-11-05. |
| VTRS - Viatris Inc | SELL | -626 @ USD 10.75 | USD -6,730 | The ETF sold 626 shares of VTRS on 2025-11-05. The shares were previously bought for an average price of USD 10.2341. The Viatris Inc shares were sold for 5.0% higher than average price of previous purchases. This sale made a profit of USD 323 The average price that the ETF previously sold VTRS share for is USD 10.9711 which is higher than the selling price of USD 10.75 on 2025-11-05. |
| UHS - Universal Health Services Inc | SELL | -31 @ USD 227.95 | USD -7,066 | The ETF sold 31 shares of UHS on 2025-11-05. The shares were previously bought for an average price of USD 191.797. The Universal Health Services Inc shares were sold for 18.8% higher than average price of previous purchases. This sale made a profit of USD 1,121 The average price that the ETF previously sold UHS share for is USD 193.071 so the ETF has sold 31 shares on 2025-11-05 at a higher price than the previous selling average. |
| COO - The Cooper Companies, Inc. Common Stock | SELL | -110 @ USD 68.88 | USD -7,577 | The ETF sold 110 shares of COO on 2025-11-05. The shares were previously bought for an average price of USD 82.9936. The The Cooper Companies, Inc. Common Stock shares were sold for -17.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,552 The average price that the ETF previously sold COO share for is USD 89.4258 which is higher than the selling price of USD 68.88 on 2025-11-05. |
| HOLX - Hologic Inc | SELL | -122 @ USD 74.23 | USD -9,056 | The ETF sold 122 shares of HOLX on 2025-11-05. The shares were previously bought for an average price of USD 67.233. The Hologic Inc shares were sold for 10.4% higher than average price of previous purchases. This sale made a profit of USD 854 The average price that the ETF previously sold HOLX share for is USD 70.5585 so the ETF has sold 122 shares on 2025-11-05 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -254 @ USD 36.84 | USD -9,357 | The ETF sold 254 shares of CNC on 2025-11-05. The shares were previously bought for an average price of USD 53.0632. The Concurrent Technologies Plc shares were sold for -30.6% lower than average price of previous purchases. This resulted in an overall loss of USD 4,121 The average price that the ETF previously sold CNC share for is USD 51.3494 which is higher than the selling price of USD 36.84 on 2025-11-05. |
| ZBH - Zimmer Biomet Holdings Inc | SELL | -109 @ USD 87.55 | USD -9,543 | The ETF sold 109 shares of ZBH on 2025-11-05. The shares were previously bought for an average price of USD 103.751. The Zimmer Biomet Holdings Inc shares were sold for -15.6% lower than average price of previous purchases. This resulted in an overall loss of USD 1,766 The average price that the ETF previously sold ZBH share for is USD 104.21 which is higher than the selling price of USD 87.55 on 2025-11-05. |
| INCY - Incyte Corporation | SELL | -91 @ USD 105.7 | USD -9,619 | The ETF sold 91 shares of INCY on 2025-11-05. The shares were previously bought for an average price of USD 74.9977. The Incyte Corporation shares were sold for 40.9% higher than average price of previous purchases. This sale made a profit of USD 2,794 The average price that the ETF previously sold INCY share for is USD 73.4904 so the ETF has sold 91 shares on 2025-11-05 at a higher price than the previous selling average. |
| DGX - Quest Diagnostics Incorporated | SELL | -61 @ USD 178.26 | USD -10,874 | The ETF sold 61 shares of DGX on 2025-11-05. The shares were previously bought for an average price of USD 171.496. The Quest Diagnostics Incorporated shares were sold for 3.9% higher than average price of previous purchases. This sale made a profit of USD 413 The average price that the ETF previously sold DGX share for is USD 166.534 so the ETF has sold 61 shares on 2025-11-05 at a higher price than the previous selling average. |
| WST - West Pharmaceutical Services Inc | SELL | -39 @ USD 283.54 | USD -11,058 | The ETF sold 39 shares of WST on 2025-11-05. The shares were previously bought for an average price of USD 258.456. The West Pharmaceutical Services Inc shares were sold for 9.7% higher than average price of previous purchases. This sale made a profit of USD 978 The average price that the ETF previously sold WST share for is USD 278.679 so the ETF has sold 39 shares on 2025-11-05 at a higher price than the previous selling average. |
| LH - Laboratory Corporation of America Holdings | SELL | -46 @ USD 250.69 | USD -11,532 | The ETF sold 46 shares of LH on 2025-11-05. The shares were previously bought for an average price of USD 253.19. The Laboratory Corporation of America Holdings shares were sold for -1.0% lower than average price of previous purchases. This resulted in an overall loss of USD 115 The average price that the ETF previously sold LH share for is USD 244.186 so the ETF has sold 46 shares on 2025-11-05 at a higher price than the previous selling average. |
| BIIB - Biogen Inc | SELL | -79 @ USD 153.43 | USD -12,121 | The ETF sold 79 shares of BIIB on 2025-11-05. The shares were previously bought for an average price of USD 143.015. The Biogen Inc shares were sold for 7.3% higher than average price of previous purchases. This sale made a profit of USD 823 The average price that the ETF previously sold BIIB share for is USD 151.452 so the ETF has sold 79 shares on 2025-11-05 at a higher price than the previous selling average. |
| PODD - Insulet Corporation | SELL | -39 @ USD 314.44 | USD -12,263 | The ETF sold 39 shares of PODD on 2025-11-05. The shares were previously bought for an average price of USD 286.796. The Insulet Corporation shares were sold for 9.6% higher than average price of previous purchases. This sale made a profit of USD 1,078 The average price that the ETF previously sold PODD share for is USD 277.173 so the ETF has sold 39 shares on 2025-11-05 at a higher price than the previous selling average. |
| WAT - Waters Corporation | SELL | -33 @ USD 371.97 | USD -12,275 | The ETF sold 33 shares of WAT on 2025-11-05. The shares were previously bought for an average price of USD 355.226. The Waters Corporation shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 553 The average price that the ETF previously sold WAT share for is USD 361.649 so the ETF has sold 33 shares on 2025-11-05 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -33 @ USD 371.97 | USD -12,275 | The ETF sold 33 shares of WAT on 2025-11-05. The shares were previously bought for an average price of USD 355.226. The MULETFWATIMETFP shares were sold for 4.7% higher than average price of previous purchases. This sale made a profit of USD 553 The average price that the ETF previously sold WAT share for is USD 361.649 so the ETF has sold 33 shares on 2025-11-05 at a higher price than the previous selling average. |
| DXCM - DexCom Inc | SELL | -216 @ USD 59.28 | USD -12,804 | The ETF sold 216 shares of DXCM on 2025-11-05. The shares were previously bought for an average price of USD 75.683. The DexCom Inc shares were sold for -21.7% lower than average price of previous purchases. This resulted in an overall loss of USD 3,543 The average price that the ETF previously sold DXCM share for is USD 76.675 which is higher than the selling price of USD 59.28 on 2025-11-05. |
| STE - STERIS plc | SELL | -54 @ USD 243.18 | USD -13,132 | The ETF sold 54 shares of STE on 2025-11-05. The shares were previously bought for an average price of USD 228.132. The STERIS plc shares were sold for 6.6% higher than average price of previous purchases. This sale made a profit of USD 813 The average price that the ETF previously sold STE share for is USD 224.516 so the ETF has sold 54 shares on 2025-11-05 at a higher price than the previous selling average. |
| MTD - Mettler-Toledo International Inc | SELL | -11 @ USD 1439.73 | USD -15,837 | The ETF sold 11 shares of MTD on 2025-11-05. The shares were previously bought for an average price of USD 1259.69. The Mettler-Toledo International Inc shares were sold for 14.3% higher than average price of previous purchases. This sale made a profit of USD 1,980 The average price that the ETF previously sold MTD share for is USD 1238.62 so the ETF has sold 11 shares on 2025-11-05 at a higher price than the previous selling average. |
| MTD - AMUNDI EUR GOV 710 | SELL | -11 @ USD 1439.73 | USD -15,837 | The ETF sold 11 shares of MTD on 2025-11-05. The shares were previously bought for an average price of USD 1259.69. The AMUNDI EUR GOV 710 shares were sold for 14.3% higher than average price of previous purchases. This sale made a profit of USD 1,980 The average price that the ETF previously sold MTD share for is USD 1238.62 so the ETF has sold 11 shares on 2025-11-05 at a higher price than the previous selling average. |
| HUM - Hummingbird Resources PLC | SELL | -66 @ USD 264.94 | USD -17,486 | The ETF sold 66 shares of HUM on 2025-11-05. The shares were previously bought for an average price of USD 266.36. The Hummingbird Resources PLC shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 94 The average price that the ETF previously sold HUM share for is USD 270.733 which is higher than the selling price of USD 264.94 on 2025-11-05. |
| HUM - Humana Inc | SELL | -66 @ USD 264.94 | USD -17,486 | The ETF sold 66 shares of HUM on 2025-11-05. The shares were previously bought for an average price of USD 266.36. The Humana Inc shares were sold for -0.5% lower than average price of previous purchases. This resulted in an overall loss of USD 94 The average price that the ETF previously sold HUM share for is USD 270.733 which is higher than the selling price of USD 264.94 on 2025-11-05. |
| GEHC - GE HealthCare Technologies Inc. | SELL | -249 @ USD 75.61 | USD -18,827 | The ETF sold 249 shares of GEHC on 2025-11-05. The shares were previously bought for an average price of USD 80.398. The GE HealthCare Technologies Inc. shares were sold for -6.0% lower than average price of previous purchases. This resulted in an overall loss of USD 1,192 The average price that the ETF previously sold GEHC share for is USD 79.2979 which is higher than the selling price of USD 75.61 on 2025-11-05. |
| IQV - IQVIA Holdings Inc | SELL | -93 @ USD 210.12 | USD -19,541 | The ETF sold 93 shares of IQV on 2025-11-05. The shares were previously bought for an average price of USD 189.983. The IQVIA Holdings Inc shares were sold for 10.6% higher than average price of previous purchases. This sale made a profit of USD 1,873 The average price that the ETF previously sold IQV share for is USD 187.998 so the ETF has sold 93 shares on 2025-11-05 at a higher price than the previous selling average. |
| RMD - ResMed Inc | SELL | -81 @ USD 245.22 | USD -19,863 | The ETF sold 81 shares of RMD on 2025-11-05. The shares were previously bought for an average price of USD 245.838. The ResMed Inc shares were sold for -0.3% lower than average price of previous purchases. This resulted in an overall loss of USD 50 The average price that the ETF previously sold RMD share for is USD 246.758 which is higher than the selling price of USD 245.22 on 2025-11-05. |
| A - Agilent Technologies Inc | SELL | -156 @ USD 146.77 | USD -22,896 | The ETF sold 156 shares of A on 2025-11-05. The shares were previously bought for an average price of USD 130.297. The Agilent Technologies Inc shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 2,570 The average price that the ETF previously sold A share for is USD 129.589 so the ETF has sold 156 shares on 2025-11-05 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -130 @ USD 196.79 | USD -25,583 | The ETF sold 130 shares of CAH on 2025-11-05. The shares were previously bought for an average price of USD 139.67. The Cardinal Health Inc shares were sold for 40.9% higher than average price of previous purchases. This sale made a profit of USD 7,426 The average price that the ETF previously sold CAH share for is USD 137.186 so the ETF has sold 130 shares on 2025-11-05 at a higher price than the previous selling average. |
| EW - Edwards Lifesciences Corp | SELL | -323 @ USD 82.84 | USD -26,757 | The ETF sold 323 shares of EW on 2025-11-05. The shares were previously bought for an average price of USD 72.9656. The Edwards Lifesciences Corp shares were sold for 13.5% higher than average price of previous purchases. This sale made a profit of USD 3,189 The average price that the ETF previously sold EW share for is USD 71.9552 so the ETF has sold 323 shares on 2025-11-05 at a higher price than the previous selling average. |
| BDX - Becton Dickinson and Company | SELL | -157 @ USD 176.39 | USD -27,693 | The ETF sold 157 shares of BDX on 2025-11-05. The shares were previously bought for an average price of USD 211.386. The Becton Dickinson and Company shares were sold for -16.6% lower than average price of previous purchases. This resulted in an overall loss of USD 5,494 The average price that the ETF previously sold BDX share for is USD 207.798 which is higher than the selling price of USD 176.39 on 2025-11-05. |
| ZTS - Zoetis Inc | SELL | -244 @ USD 120.49 | USD -29,400 | The ETF sold 244 shares of ZTS on 2025-11-05. The shares were previously bought for an average price of USD 160.186. The Zoetis Inc shares were sold for -24.8% lower than average price of previous purchases. This resulted in an overall loss of USD 9,686 The average price that the ETF previously sold ZTS share for is USD 167.894 which is higher than the selling price of USD 120.49 on 2025-11-05. |
| IDXX - IDEXX Laboratories Inc | SELL | -44 @ USD 720.21 | USD -31,689 | The ETF sold 44 shares of IDXX on 2025-11-05. The shares were previously bought for an average price of USD 501.086. The IDEXX Laboratories Inc shares were sold for 43.7% higher than average price of previous purchases. This sale made a profit of USD 9,641 The average price that the ETF previously sold IDXX share for is USD 474.033 so the ETF has sold 44 shares on 2025-11-05 at a higher price than the previous selling average. |
| REGN - Regeneron Pharmaceuticals Inc | SELL | -56 @ USD 644.19 | USD -36,075 | The ETF sold 56 shares of REGN on 2025-11-05. The shares were previously bought for an average price of USD 655.6. The Regeneron Pharmaceuticals Inc shares were sold for -1.7% lower than average price of previous purchases. This resulted in an overall loss of USD 639 The average price that the ETF previously sold REGN share for is USD 683.045 which is higher than the selling price of USD 644.19 on 2025-11-05. |
| COR - Cencora Inc. | SELL | -106 @ USD 354 | USD -37,524 | The ETF sold 106 shares of COR on 2025-11-05. The shares were previously bought for an average price of USD 290.556. The Cencora Inc. shares were sold for 21.8% higher than average price of previous purchases. This sale made a profit of USD 6,725 The average price that the ETF previously sold COR share for is USD 267.068 so the ETF has sold 106 shares on 2025-11-05 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -147 @ USD 259.58 | USD -38,158 | The ETF sold 147 shares of CI on 2025-11-05. The shares were previously bought for an average price of USD 307.538. The Cigna Corp shares were sold for -15.6% lower than average price of previous purchases. This resulted in an overall loss of USD 7,050 The average price that the ETF previously sold CI share for is USD 316.641 which is higher than the selling price of USD 259.58 on 2025-11-05. |
| ELV - Elevance Health Inc | SELL | -124 @ USD 318.08 | USD -39,442 | The ETF sold 124 shares of ELV on 2025-11-05. The shares were previously bought for an average price of USD 384.663. The Elevance Health Inc shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 8,256 The average price that the ETF previously sold ELV share for is USD 392.661 which is higher than the selling price of USD 318.08 on 2025-11-05. |
| ELV - Elevance Health Inc | SELL | -124 @ USD 318.08 | USD -39,442 | The ETF sold 124 shares of ELV on 2025-11-05. The shares were previously bought for an average price of USD 384.663. The Elevance Health Inc shares were sold for -17.3% lower than average price of previous purchases. This resulted in an overall loss of USD 8,256 The average price that the ETF previously sold ELV share for is USD 392.661 which is higher than the selling price of USD 318.08 on 2025-11-05. |
| HCA - HCA Holdings Inc | SELL | -90 @ USD 473.2 | USD -42,588 | The ETF sold 90 shares of HCA on 2025-11-05. The shares were previously bought for an average price of USD 366.381. The HCA Holdings Inc shares were sold for 29.2% higher than average price of previous purchases. This sale made a profit of USD 9,614 The average price that the ETF previously sold HCA share for is USD 365.279 so the ETF has sold 90 shares on 2025-11-05 at a higher price than the previous selling average. |
| BMY - Bloomsbury Publishing Plc | SELL | -1,116 @ USD 46.47 | USD -51,861 | The ETF sold 1116 shares of BMY on 2025-11-05. The shares were previously bought for an average price of USD 52.6744. The Bloomsbury Publishing Plc shares were sold for -11.8% lower than average price of previous purchases. This resulted in an overall loss of USD 6,924 The average price that the ETF previously sold BMY share for is USD 53.3337 which is higher than the selling price of USD 46.47 on 2025-11-05. |
| CVS - CVS Health Corp | SELL | -695 @ USD 78.55 | USD -54,592 | The ETF sold 695 shares of CVS on 2025-11-05. The shares were previously bought for an average price of USD 67.553. The CVS Health Corp shares were sold for 16.3% higher than average price of previous purchases. This sale made a profit of USD 7,643 The average price that the ETF previously sold CVS share for is USD 61.2639 so the ETF has sold 695 shares on 2025-11-05 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -68 @ USD 844.26 | USD -57,410 | The ETF sold 68 shares of MCK on 2025-11-05. The shares were previously bought for an average price of USD 673.553. The McKesson Corporation shares were sold for 25.3% higher than average price of previous purchases. This sale made a profit of USD 11,608 The average price that the ETF previously sold MCK share for is USD 656.271 so the ETF has sold 68 shares on 2025-11-05 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -141 @ USD 417 | USD -58,797 | The ETF sold 141 shares of VRTX on 2025-11-05. The shares were previously bought for an average price of USD 450.219. The Vertex Pharmaceuticals Inc shares were sold for -7.4% lower than average price of previous purchases. This resulted in an overall loss of USD 4,684 The average price that the ETF previously sold VRTX share for is USD 468.84 which is higher than the selling price of USD 417 on 2025-11-05. |
| MDT - Medtronic PLC | SELL | -704 @ USD 90.4 | USD -63,642 | The ETF sold 704 shares of MDT on 2025-11-05. The shares were previously bought for an average price of USD 90.036. The Medtronic PLC shares were sold for 0.4% higher than average price of previous purchases. This sale made a profit of USD 256 The average price that the ETF previously sold MDT share for is USD 87.2949 so the ETF has sold 704 shares on 2025-11-05 at a higher price than the previous selling average. |
| SYK - Stryker Corporation | SELL | -189 @ USD 357.67 | USD -67,600 | The ETF sold 189 shares of SYK on 2025-11-05. The shares were previously bought for an average price of USD 377.159. The Stryker Corporation shares were sold for -5.2% lower than average price of previous purchases. This resulted in an overall loss of USD 3,683 The average price that the ETF previously sold SYK share for is USD 380.389 which is higher than the selling price of USD 357.67 on 2025-11-05. |
| DHR - Danaher Corporation | SELL | -349 @ USD 212.21 | USD -74,061 | The ETF sold 349 shares of DHR on 2025-11-05. The shares were previously bought for an average price of USD 213.406. The Danaher Corporation shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 417 The average price that the ETF previously sold DHR share for is USD 222.264 which is higher than the selling price of USD 212.21 on 2025-11-05. |
| DHR - Danaher Corporation | SELL | -349 @ USD 212.21 | USD -74,061 | The ETF sold 349 shares of DHR on 2025-11-05. The shares were previously bought for an average price of USD 213.406. The Danaher Corporation shares were sold for -0.6% lower than average price of previous purchases. This resulted in an overall loss of USD 417 The average price that the ETF previously sold DHR share for is USD 222.264 which is higher than the selling price of USD 212.21 on 2025-11-05. |
| PFE - Pfizer Inc | SELL | -3,124 @ USD 24.61 | USD -76,882 | The ETF sold 3124 shares of PFE on 2025-11-05. The shares were previously bought for an average price of USD 25.4154. The Pfizer Inc shares were sold for -3.2% lower than average price of previous purchases. This resulted in an overall loss of USD 2,516 The average price that the ETF previously sold PFE share for is USD 25.3613 which is higher than the selling price of USD 24.61 on 2025-11-05. |
| BSX - Boston Scientific Corporation | SELL | -814 @ USD 98.9 | USD -80,505 | The ETF sold 814 shares of BSX on 2025-11-05. The shares were previously bought for an average price of USD 99.2981. The Boston Scientific Corporation shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 324 The average price that the ETF previously sold BSX share for is USD 94.5801 so the ETF has sold 814 shares on 2025-11-05 at a higher price than the previous selling average. |
| BSX - MULSTRXSSXIMETFP | SELL | -814 @ USD 98.9 | USD -80,505 | The ETF sold 814 shares of BSX on 2025-11-05. The shares were previously bought for an average price of USD 99.2981. The MULSTRXSSXIMETFP shares were sold for -0.4% lower than average price of previous purchases. This resulted in an overall loss of USD 324 The average price that the ETF previously sold BSX share for is USD 94.5801 so the ETF has sold 814 shares on 2025-11-05 at a higher price than the previous selling average. |
| GILD - Guild Esports Plc | SELL | -682 @ USD 122.58 | USD -83,600 | The ETF sold 682 shares of GILD on 2025-11-05. The shares were previously bought for an average price of USD 107.07. The Guild Esports Plc shares were sold for 14.5% higher than average price of previous purchases. This sale made a profit of USD 10,578 The average price that the ETF previously sold GILD share for is USD 100.346 so the ETF has sold 682 shares on 2025-11-05 at a higher price than the previous selling average. |
| AMGN - Amgen Inc | SELL | -296 @ USD 319.86 | USD -94,679 | The ETF sold 296 shares of AMGN on 2025-11-05. The shares were previously bought for an average price of USD 298.089. The Amgen Inc shares were sold for 7.3% higher than average price of previous purchases. This sale made a profit of USD 6,444 The average price that the ETF previously sold AMGN share for is USD 293.813 so the ETF has sold 296 shares on 2025-11-05 at a higher price than the previous selling average. |
| ISRG - Intuitive Surgical Inc | SELL | -197 @ USD 548.55 | USD -108,064 | The ETF sold 197 shares of ISRG on 2025-11-05. The shares were previously bought for an average price of USD 516.602. The Intuitive Surgical Inc shares were sold for 6.2% higher than average price of previous purchases. This sale made a profit of USD 6,294 The average price that the ETF previously sold ISRG share for is USD 528.532 so the ETF has sold 197 shares on 2025-11-05 at a higher price than the previous selling average. |
| MRK - Marks Electrical Group PLC | SELL | -1,372 @ USD 84.39 | USD -115,783 | The ETF sold 1372 shares of MRK on 2025-11-05. The shares were previously bought for an average price of USD 89.0875. The Marks Electrical Group PLC shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,445 The average price that the ETF previously sold MRK share for is USD 92.9733 which is higher than the selling price of USD 84.39 on 2025-11-05. |
| MRK - Merck & Company Inc | SELL | -1,372 @ USD 84.39 | USD -115,783 | The ETF sold 1372 shares of MRK on 2025-11-05. The shares were previously bought for an average price of USD 89.0875. The Merck & Company Inc shares were sold for -5.3% lower than average price of previous purchases. This resulted in an overall loss of USD 6,445 The average price that the ETF previously sold MRK share for is USD 92.9733 which is higher than the selling price of USD 84.39 on 2025-11-05. |
| TMO - Time Out Group plc | SELL | -207 @ USD 567.64 | USD -117,501 | The ETF sold 207 shares of TMO on 2025-11-05. The shares were previously bought for an average price of USD 512.89. The Time Out Group plc shares were sold for 10.7% higher than average price of previous purchases. This sale made a profit of USD 11,333 The average price that the ETF previously sold TMO share for is USD 494.888 so the ETF has sold 207 shares on 2025-11-05 at a higher price than the previous selling average. |
| ABT - Abbott Laboratories | SELL | -956 @ USD 124.54 | USD -119,060 | The ETF sold 956 shares of ABT on 2025-11-05. The shares were previously bought for an average price of USD 128.54. The Abbott Laboratories shares were sold for -3.1% lower than average price of previous purchases. This resulted in an overall loss of USD 3,824 The average price that the ETF previously sold ABT share for is USD 123.128 so the ETF has sold 956 shares on 2025-11-05 at a higher price than the previous selling average. |
| UNH - UnitedHealth Group Incorporated | SELL | -497 @ USD 327.74 | USD -162,887 | The ETF sold 497 shares of UNH on 2025-11-05. The shares were previously bought for an average price of USD 452.79. The UnitedHealth Group Incorporated shares were sold for -27.6% lower than average price of previous purchases. This resulted in an overall loss of USD 62,150 The average price that the ETF previously sold UNH share for is USD 482.367 which is higher than the selling price of USD 327.74 on 2025-11-05. |
| ABBV - AbbVie Inc | SELL | -970 @ USD 216.77 | USD -210,267 | The ETF sold 970 shares of ABBV on 2025-11-05. The shares were previously bought for an average price of USD 201.07. The AbbVie Inc shares were sold for 7.8% higher than average price of previous purchases. This sale made a profit of USD 15,229 The average price that the ETF previously sold ABBV share for is USD 189.868 so the ETF has sold 970 shares on 2025-11-05 at a higher price than the previous selling average. |
| JNJ - Johnson & Johnson | SELL | -1,323 @ USD 186 | USD -246,078 | The ETF sold 1323 shares of JNJ on 2025-11-05. The shares were previously bought for an average price of USD 165.15. The Johnson & Johnson shares were sold for 12.6% higher than average price of previous purchases. This sale made a profit of USD 27,585 The average price that the ETF previously sold JNJ share for is USD 157.281 so the ETF has sold 1323 shares on 2025-11-05 at a higher price than the previous selling average. |
| LLY - Eli Lilly and Company | SELL | -437 @ USD 925.81 | USD -404,579 | The ETF sold 437 shares of LLY on 2025-11-05. The shares were previously bought for an average price of USD 817.046. The Eli Lilly and Company shares were sold for 13.3% higher than average price of previous purchases. This sale made a profit of USD 47,530 The average price that the ETF previously sold LLY share for is USD 796.232 so the ETF has sold 437 shares on 2025-11-05 at a higher price than the previous selling average. |